Facts & Figures

750
Organizations
49,000
Employees
22.7 bn
Sales / Year
8,800
Publications
Source: Vienna Life Science Report 2024/25 (Data: 2023) More Information

News

Valneva Reports Positive Results for Phase 1 Trial of Second Generation Zika Vaccine Candidate

Immune response successfully improved with second generation vaccine candidate

UpNano: From Nanometers to Industry: High-Resolution 2PP 3D Printing Now in China

Collaboration between UpNano and Husun Technologies brings high-resolution 2PP 3D-printing to one of the world’s largest…

Hookipa Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead

Hookipa Pharma Inc. (OTCID: HOOK, “HOOKIPA”) today announced the completion of the sale of its assets related to…

All news

Driven by curiosity, inspired by our city...

Events

Vienna

IMP: 40 Years of Finding Out

On Wednesday, 5 November 2025, the IMP will mark its 40th anniversary with a one-day symposium that brings together past…

5.11. - 7.11.2025

Vienna

22nd Vienna Biocenter PhD Symposium: Bringing it all back Home - Vienna BioCenter Alumni reunion

The symposium will be an opportunity to connect the current members and alumni of the Vienna BioCenter through our…

Wien, online

Pharmig Academy: Qualitätsmanagement & GxP: Kompetent handeln im regulatorischen Umfeld - Modul 4

GDP & Logistik: Sichere Lagerung und Distribution in der pharmazeutischen Supply Chain

All events